However, while p53 mutations often lead to p53 inactivation, many mutations retain significant activity [54] or even acquire oncogenic properties and thus drive tumor formation, invasion and metastasis through gain-of-function activities or dominant negative inhibition of wild-type p53 [55]. Here, TP53 is linked to neoplasm.